Stocks · Korea
018680
KOSDAQ
Seoul Pharma
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+1.36%
1M-1.07%
3M-13.53%
6M-28.52%
1Y-39.09%
YTD-36.70%
52W high3,310원
52W low1,820원
From 52W high-41.48%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 501억 | 17억 | 9억 | 3.5% |
| 2023 | 525억 | 12억 | 35억 | 2.3% |
| 2024 | 536억 | 15억 | 17억 | 2.9% |
| 2025 | 521억 | -13억 | 8억 | -2.5% |
| Quarterly | ||||
| 2024 4Q | 139억 | 6억 | 7억 | 4.5% |
| 2025 1Q | 129억 | -1억 | -2억 | -0.9% |
| 2025 2Q | 120억 | -9억 | -13억 | -7.6% |
| 2025 3Q | 136억 | -33,603,519원 | 26억 | -0.2% |
| 2025 4Q | 136억 | -2억 | -4억 | -1.6% |
| 2026 1Q | 121억 | -2억 | -2억 | -1.5% |
Company
Address: 충청북도 청주시 흥덕구 오송읍 오송생명6로 124-31 서울제약 오송공장
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 텔콘RF제약 | 227억 | — | 0.15 | +3.37% |
| 풍전약품 | 225억 | 77.83 | 0.57 | -7.34% |
| 대성미생물 | 229억 | 38.41 | 0.65 | -3.37% |
| 엠에프씨 | 224억 | 25.34 | 0.70 | +4.61% |
| 에이프로젠바이오로직스 | 250억 | — | 0.10 | -10.83% |
| 엑셀세라퓨틱스 | 179억 | — | 2.51 | -7.59% |
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.